Despite the fact that respiratory infections and health conditions are already stated as contraindications for HBOT, the situation of SARS-CoV-2 is undoubtedly an exception. Today, the potential utilization of HBOT in the COVID-19 has become specially regarded, exposing results in quite a few managed scientific trials. Furthermore, the use of this